Pear Therapeutics

Steve Sherman


Steve Sherman comes with several years of increasing responsibility in regulatory affairs, most recently as the Senior Vice President of Regulatory Affairs at Insys Therapeutics, where he was responsible for programs in pediatric epilepsy, schizophrenia, and opioid use disorder, among others. Several of the projects Steve was responsible for were drug-device combination products. In prior positions at companies such as Novartis, Abbott Laboratories, and Shire, Steve worked on products in the areas of oncology, cardiovascular disease, CNS, depression, and other therapeutic areas in both large and small companies.

Steve also worked at the FDA as a Regulatory Review Officer and started in sales and marketing. He has a Juris Doctorate, an MBA in marketing, and bachelor’s in Biology.